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OBJECTIVEdTo develop a linguistically and psychometrically validated U.K. English (U.K./
Ireland) version of the Diabetes-Speciﬁc Quality-of-Life Scale (DSQOLS) for adults with type 1
diabetes.
RESEARCH DESIGN AND METHODSdWe conducted independent forward and
backward translation of the validated German DSQOLS. An iterative interview study with health
professionals (n = 3) and adults with type 1 diabetes (n = 8) established linguistic validity. The
DSQOLS was included in three Dose Adjustment for Normal Eating (DAFNE) studies (total N =
1,071). Exploratory factor analysis (EFA) was undertaken to examine questionnaire structure.
Concurrent and discriminant validity, internal consistency, and reliability were assessed.
RESULTSdEFA indicated a six-factor structure for the DSQOLS (social aspects, fear of hy-
poglycemia, dietary restrictions, physical complaints, anxiety about the future, and daily has-
sles). High internal consistency reliability was found for these factors and the weighted treatment
satisfaction scale (a = 0.85–0.94). All subscales were moderately, positively correlated with the
Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) measure, demonstrating evidence of
concurrent validity. Lower DSQOLS subscale scores [indicating impaired quality of life (QoL)]
were associated with the presence of diabetes-related complications.
CONCLUSIONSdThe DSQOLS captures the impact of detailed aspects of modern type 1 di-
abetes management (e.g., carbohydrate counting and ﬂexible insulin dose adjustment) that are now
routine in many parts of the U.K. and Ireland. The U.K. English version of the DSQOLS offers a
valuable tool for assessing the impact of treatment approaches onQoL in adults with type 1 diabetes.
Diabetes Care 36:1117–1125, 2013
F
or people living with type 1 diabetes,
the daily challenge is to strike an
acceptable balance of self-care activities
to achieve optimal glycemic outcomes with-
out damagingquality of life (QoL).Glycemic
control is objective, easy to measure, and
emphasized in clinical studies. QoL is
subjective, poses signiﬁcant measurement
challenges, and is often forgotten or
ignored. Over 10 years ago, a prominent
U.S. psychologist urged that behavioral
outcomes in diabetes studies be accorded
the same importance as biomedical out-
comes (1). More recently, the U.K. Na-
tional Institute for Health and Clinical
Excellence has recognized QoL as an im-
portant treatment goal in diabetes (2).
The need to assess patient-reported out-
come measures has been recognized by
the U.K. Department of Health with, for
example, introduction of the requirement
to capture patient-reported assessment of
health before and after certain elective
procedures (3). The U.S. Food and Drug
Administration has also issued deﬁnitive
guidance promoting the use of patient-
reported outcome measures in medicinal
labeling claims (4).
Diabetes self-management education
programs have been part of routine care
in countries like the U.S., Germany, and
Austria for several decades but intro-
duced in the U.K. and Ireland only in
the past decade. Their importance has
been endorsed in National Institute for
Health and Clinical Excellence guidance
on patient education models (2) and
through the National Service Framework
for Diabetes in the U.K. (5,6). A joint
Department of Health, National Health
Service, and Diabetes UK initiative
provided a tool kit for commissioners
to evaluate diabetes education provision
within their services (7). This report
fell short of offering guidance on the eval-
uation of diabetes education at the indivi-
dual patient level. A recent national
consensus report from Australia ad-
dressed this issue and provided guidance
on how to evaluate diabetes educa-
tion across a spectrum of outcomes
including knowledge, self-management,
self-determination, and psychological
adjustment, with the latter including
QoL (8).
The Dose Adjustment for Normal
Eating (DAFNE) program is a collabora-
tive of clinicians, social scientists, and
health economists actively delivering
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and evaluating skill-based structured
education promoting ﬂexible, intensive
insulin therapy for adults with type 1 di-
abetes. The collaborative has identiﬁed a
need to improve the existing approach to
assessing outcomes of diabetes struc-
tured education.
In a recent review of English-language
instruments commonly used to assess
QoL, the authors caution against the
frequent oversimpliﬁcation that all psy-
chosocial assessments measure QoL;
some do, but others quantify related but
separate constructs such as treatment
satisfaction, psychological well-being,
and health status (9). A number of instru-
ments have been developed to measure
the impact of diabetes on QoL: the Audit
of Diabetes-Dependent Quality-of-Life
(ADDQoL) (10), the Diabetes Quality-of-
Life (DQOL) scale (11), and the Diabetes-
Speciﬁc Quality-of-Life Scale (DSQOLS)
(12). Used in the original DAFNE trial
(13), the ADDQoL was sensitive to the
beneﬁts of ﬂexible, intensive insulin ther-
apy but considered too lengthy for future
routine use, and the use of hypothetical
scenarios was considered too complex
for some respondents (9,14). The DQOL
has been used widely with somewhat
disappointing results. In particular, the
reported lack of difference between in-
tensiﬁed and conventional treatment
groups in the Diabetes Control and Com-
plications Trial (15) is likely to be “attrib-
utable to the limitations of the measure
rather than to any real lack of impact of
intensiﬁcation of treatment onQoL” (16).
Over 20 years old, many of the items are
outdated now, and we have found, in our
recent experience of using it in the U.K.,
that respondents ﬁnd it frustrating to
complete. Recognizing that the DQOL
was low on sensitivity and discriminant
validity, Bott et al. (12) designed the
DSQOLS. It was designed speciﬁcally
for people with type 1 diabetes using
modern insulin regimens and has proven
sensitive to differences between various
insulin regimens, as well as between con-
ventional insulin treatment and insulin
pump therapy (12,17).
The original version of the DSQOLS
was developed and validated in German
(12). In this report, we describe the
linguistic and psychometric validation
of a U.K. English-language version of
the DSQOLS. The performance of
the questionnaire was assessed using
data from three groups of adults with
type 1 diabetes undertaking DAFNE
education.
RESEARCH DESIGN AND
METHODS
DSQOLS
The original 64-item DSQOLS was de-
signed in Germany speciﬁcally for peo-
ple with type 1 diabetes (12). It includes
44 burden items measuring the impact
of diabetes on “social relations,” “leisure
time ﬂexibility,” “diet restrictions,”
“physical complaints,” “daily hassles,”
and “worries about the future.” Re-
spondents are asked to rate the extent
to which each of the statements meets
their “point of view” on a 6-point Likert
scale: from “perfectly” to “not at all.” A
further 10 items measure treatment sat-
isfaction (on a 6-point scale from “very
satisﬁed” to “very dissatisﬁed”), and 10
more assess the personal importance of
treatment goals on a 6-point Likert scale
from “very important” to “totally unim-
portant.” The design of the DSQOLS
was based on interviews with adults
with type 1 diabetes, but its precise de-
velopment and item generation were not
described in detail (12). Psychometric
validation of the original DSQOLS was
undertaken using data from a sample of
657 people with type 1 diabetes attend-
ing general practice in the North Rhine
region of Germany (12). A systematic
review of patient-completed health out-
come measures for diabetes concluded
that there was good evidence for the re-
liability and internal and external con-
struct validity of the German-language
version of DSQOLS (18).
The original German-language ver-
sion was later revised after further un-
published validation work (U. Bott,
unpublished observations). Eleven
items were retained without modiﬁca-
tion, but 27 items were amended
slightly to aid interpretation (e.g., “dia-
betes restrains my future plans”
amended to “diabetes interferes with
my future plans”). Six items were omit-
ted because of low item-scale correla-
tions in their original analyses or weak
factor loadings (,0.3). Nineteen addi-
tional items were introduced, 11 of
which to assess fear of hypoglycemia.
Thus, this revised version of the
DSQOLS includes a total of 77 items,
comprising 10 individual treatment
goal items, 10 treatment-satisfaction
items, and 57 diabetes-speciﬁc burden
items. The validation work presented
here is based upon this revised version
of the German DSQOLS.
Translation and linguistic
validation of the DSQOLS into
English (U.K. and Ireland)
Although the original DSQOLS was val-
idated in German and not English, it was
ﬁrst described in an English-language
journal (12) in which an English version
was presented, though this was not a ro-
bust translation and was not linguistically
validated. The DSQOLS has not, to our
knowledge, been translated into any other
languages. The revised German DSQOLS
and its unauthorized English translation
were obtained from the authors. An inde-
pendent translator, bilingual in German
and English, who had not seen the ques-
tionnaire, carried out a second forward
translation from German into U.K. En-
glish. Following international guidelines
for translation and cultural adaptation of
questionnaires (19), the translator aimed
for conceptual and cultural equivalence
of words/phrases. This second forward
translation was compared directly with
the ﬁrst and discussed with a psychologist
(D.C.). The main discrepancies com-
prised reliance on overly technical terms.
This process resulted in a reconciled U.K.
English version, which a second, inde-
pendent translator (R.L.M.) then back-
translated into German. Discrepancies
with the revised German DSQOLS were
discussed, resolved, and agreed upon be-
tween R.L.M., D.C., and the ﬁrst transla-
tor. The few discrepancies identiﬁed
concerned the meaning of particular
phrases and conceptual equivalence.
To ensure content validity, clinicians
and a psychologist reviewed the ﬁnal
English version of the questionnaire to
assess its relevance, appropriateness, clar-
ity, and comprehensiveness. Cognitive
debrieﬁng (a think-aloud technique) was
used to pilot this version with four
DAFNE participants in Galway, Ireland.
They commented on the questionnaire;
its layout, comprehensiveness, redun-
dancy, and ease of understanding and
completion; length of time taken to com-
plete it; and any additional comments.
Feedback, at this stage of piloting, indi-
cated that the questionnaire was com-
prehensible and acceptable with one
exception. Response options for the 57
burden itemswere amended slightly so that
people were asked to rate their agreement
with the statements on a 6-point Likert
scale labeled “very strongly agree” to “do
not agree at all” rather than “perfectly” to
“not at all.” This version was discussed
with a further four participants from the
same center who indicated that questions
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and response options made sense and lan-
guage was clear.
Population
Baseline data were analyzed from three
studies within the DAFNE Collaborative.
The Database Study collects comprehen-
sive biomedical and psychosocial data
from participants at ten centers in the
U.K. (20). The Irish study is a cluster-
randomized trial evaluating two different
methods of follow-up of DAFNE gradu-
ates (21). The psychosocial study is a
longitudinal evaluation of structured edu-
cation conducted to identify predictors of
QoL and glycemic outcomes. Ethics ap-
provals were obtained from the Trent Re-
search Ethics Committee (REC), National
University of Ireland Galway REC, and
King’s College REC, respectively. Inclu-
sion criteria were similar for each study:
adults (aged $17 years) with type 1 dia-
betes of at least 6-months’ duration who
had agreed to participate in the DAFNE
program. Eligible participants were re-
cruited from 10 hospitals in England for
the “database study,” 6 hospitals in Ireland
for the “Irish study,” and 12 hospitals in
England and Scotland for the “psychoso-
cial study.”
Study variables
The DSQOLS was completed by all par-
ticipants in each study prior to receiving
DAFNE training along with other psycho-
social measures. The ADDQoL (10,22) was
completed by a subsample of participants
(n = 42) in the Irish study at baseline to
assess concurrent validity. The ADDQoL
provides a composite rating of the average
weighted impact (AWI) of diabetes, de-
rived from ratings of 18 potentially appli-
cable domains of life (e.g., “working life,”
“family life”), indicating the individualized
impact of diabetes on the domain (i.e., im-
pact 23 to 1, weighted by importance
0–3). The AWI score is derived by dividing
the sum of the weighted ratings by the
number of applicable domains. Scores
for single domains and the AWI range
from 29 (maximum negative impact of
diabetes) to 9 (maximum positive im-
pact of diabetes). Two overview items,
scored individually, measure “present
quality of life” [scores ranging from
23 (extremely bad) to 3 (excellent)]
and “diabetes-dependent QoL” [scores
ranging from 23 (maximum negative
impact of diabetes) to 3 (maximumpositive
impact of diabetes)].
The WHO-5 (version 5 of the World
Health Organization Well-Being Index)
Table 1dSample characteristics and DSQOLS scores
Database study
Irish study
Psychosocial
study*EFA CFA
Total n 510 511 438 262
Age (years)
n 509 510 438 262
Mean (SD) 40 (13) 40 (14) 38 (12) 40 (14)
Range 18–73 17–78 18–74 17–73
Sex (% female) 241 (47%) 254 (50%) 233 (53%) 131 (50%)
Duration (years)
n 503 507 435 262
Mean (SD) 17 (13) 17 (13) 16 (11) 18 (13)
Range 0–65 0–55 1–58 0–55
HbA1c
n 496 480 438 262
Mean (SD) 8.8 (1.6) 8.7 (1.6) 8.3 (1.3) 8.5 (1.5)
Range 4.9–16.6 5.2–14.9 5.0–13.5 5.4–14.2
Presence of complications 193 (38%) 203 (45%) d d
DSQOLS: total group**
Social aspects
n 970
Mean (SD) 75.6 (19.2)
Range 0–100
Participants at ﬂoor 0.1
Participants at ceiling 2.7
Fear of hypoglycemia
n 970
Mean (SD) 67.0 (23.8)
Range 0–100
Participants at ﬂoor 0.3
Participants at ceiling 5.4
Dietary restrictions
n 969
Mean (SD) 65.1 (23.7)
Range 0–100
Participants at ﬂoor 0.3
Participants at ceiling 4.7
Physical complaints
n 970
Mean (SD) 68.4 (21.8)
Range 0–100
Participants at ﬂoor 0.3
Participants at ceiling 3.7
Anxiety about the future
n 970
Mean (SD) 44.5 (26.5)
Range 0–100
Participants at ﬂoor 4.2
Participants at ceiling 2.0
Daily hassles
n 972
Mean (SD) 55.0 (25.0)
Range 0–100
Participants at ﬂoor 2.1
Participants at ceiling 3.5
Total score (burden)
n 966
Continued on p. 1120
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includes ﬁve statements (e.g., “I have felt
cheerful and in good spirits”) assessing
positively worded depressed mood. Re-
spondents rate their agreement with
each item, using a 6-point Likert scale
from 0, “none of the time,” to 5, “all of
the time,” in relation to the past 2 weeks
(23,24). Items are summed to form a total
well-being score (ranging from 0 to 25),
with higher scores representing greater
well-being (or less depressed mood).
A single-item, global measure of life
satisfaction was used from the fourth
edition of the Personal Well-Being Index
for Adults (25). This asks participants to
rate their satisfaction with their “life right
now” on a 10-point Likert scale from 0,
“completely dissatisﬁed,” to 10, “com-
pletely satisﬁed.”
The latter two measures were com-
pleted only by participants in the psycho-
social study and were used to assess
discriminant validity. For all three studies,
demographic and clinical data were col-
lected, including the presence of long-term
complications of diabetes (retinopathy, ne-
phropathy, neuropathy, or macrovascular
disease or sequelae thereof).
Analysis
In order to determine the structure of the
57 DSQOLS burden items, the database
study sample (N = 1,021) was split ran-
domly in two (using SPSS), with one-half
of the sample used for exploratory factor
analyses (EFAs) (n = 510) and one-half
used for conﬁrmatory factor analysis
(CFA) (n = 511). Experts differ in their
recommendations for the minimum sam-
ple size required for conducting factor
analyses. Comfrey and Lee (26) consider
a sample size of 300 as good and 500
very good, while Gorsuch (27) makes rec-
ommendations based on the ratio of partic-
ipants to items, stating that a minimum of
ﬁve participants is required per item. Thus,
with 57 items, aminimum sample of 285 is
required. In a review of studies that recom-
mended minimum sample sizes for this
type of analysis, 400 was the upper limit
of the recommendations (28). EFAwas car-
ried out using maximum likelihood with
Geomin oblique rotation to obtain stan-
dardized estimates. Item-component load-
ings of .0.30 were considered signiﬁcant
based on recommendations for minimum
loading of an item (29).
CFA was used to conﬁrm the factor
structure of the 57 DSQOLS burden items
using the total sample from the database
study. x2, comparative ﬁt index (CFI), a
root mean square error of approximation
(RMSEA), and standardized root mean
square residual (SRMR) were used to eval-
uate the ﬁt between the model and the
data. CFIs of $0.90 indicate a good ﬁt
to the data (30). A RMSEA value ,0.08
indicates an acceptable ﬁt to the data,
while values ,0.05 indicate a good ﬁt to
the data (30). Well-ﬁtting models obtain
SRMR values,0.05, but values as high as
0.08 are deemed acceptable (31).
Internal consistency reliability was
evaluated using Cronbach a statistics
and item-total correlations. As recom-
mended by Bott et al. (12), for facilitation
of comparability of the different DSQOLS
scores, crude scores were converted to a
100% scale (score 2 minimum score) 3
100/(maximum score 2 minimum
score). Higher scores on each subscale
indicate a better QoL (i.e., less negative
impact of diabetes) or greater satisfaction
with treatment. For calculation of the
preference-weighted treatment satisfaction
score (PWTSS), ratings on each treatment
goal are multiplied by the corresponding
degree of satisfaction with the achievement
of those goals. The sum of those 10 prod-
ucts gives the PWTSS, which is converted
to a 100% scale.
Concurrent validity was assessed by
correlating (Pearson r) DSQOLS subscale
scores, including the PWTSS, with each
other and (using a subsample of 42 from
the Irish study) with scores on another, val-
idated measure of diabetes-speciﬁc QoL,
the ADDQoL (10). Moderate to strong rela-
tionships were expected between the
DSQOLS subscales, ADDQoL AWI score,
and diabetes-dependentQoL overview item.
Discriminant validity was assessed by
correlating (Pearson r) the DSQOLS sub-
scales, including the PWTSS, and total score
with measures of depressed mood (WHO-
5), generic QoL (ADDQoL “present QoL”
overview item), and “life satisfaction,” with
weak tomoderate correlations expected (32).
With data from the database study,
known-groups validity was assessed by
comparing the scores on the DSQOLS
subscales, including the PWTSS, between
those with diagnosed diabetes-related
complications and those without. It was
expected that those with complications
would report signiﬁcantly lower DSQOLS
subscales scores, indicating that diabetes
impaired their QoL. Statistical analyses
were conducted using SPSS, version 17.0,
and Mplus 6.1 software.
RESULTS
Population characteristics
The demographic and clinical character-
istics of each study group were very
similar (Table 1). The mean age ranged
from 38 to 40 years, with mean diabetes
duration ranging from 16 to 18 years
and mean baseline HbA1c ranging from
8.3 to 8.8%. Complications data are pre-
sented only for participants of the Database
Study. Of the 911 (89%) participants for
whom data were available, 396 (44%) had
one or more long-term complications of
diabetes.
DSQOLS structure
For this analysis, data were available for
995 of 1,021 database study participants.
Twenty-four had more than one-half of
their data missing; hence, the initial EFA
was based on n = 491 and the CFA on
n = 480. Of these 971 case subjects, 966
had completed all DSQOLS questions.
Five participants had missed one or two
Table 1dContinued
Database study
Irish study
Psychosocial
study*EFA CFA
Mean (SD) 66.7 (18.5)
Range 4.6–100
Participants at ﬂoor 0
Participants at ceiling 0.1
DSQOLS PWTSS
n 986
Mean (SD) 58.1 (13.8)
Range 4.0–95.0
Participants at ﬂoor 0
Participants at ceiling 0
Data are percent unless otherwise indicated. *Majority of participants in the psychosocial study are included
within the database study. **Descriptives from database study participants (total group).
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Table 2dFactor loadings for the 57 items relating to daily restrictions and burdens [presented in order of strength of factor loadings, with the
highest factor loadings presented in boldface (database study EFA sample)]
Item no.
(English version) Item wording
Social
aspects
Fear of
hypoglycemia
Dietary
restraint
Physical
complaints
Anxiety
about future
Daily
hassles
40 Because of diabetes I cannot pursue my
hobbies as I wish 0.752 20.039 0.032 0.052 0.024 20.070
51 Because of diabetes it is much harder to
make friends 0.703 0.180 0.023 20.025 20.209 20.100
49 Because of diabetes my family
life is affected 0.695 20.042 0.001 0.002 0.101 0.015
34 Because of my diabetes I cannot spend
my free time the way I would like 0.680 20.067 0.146 0.094 0.002 20.006
28 Because of diabetes I have less contact
with friends or acquaintances 0.661 0.022 20.038 0.132 20.151 20.011
35 I feel like a disabled person 0.617 0.020 20.008 0.220 20.013 0.035
44 Diabetes constantly causes problems
while dealing with other people 0.599 0.170 0.106 0.052 20.107 20.140
6 I feel as if I am less attractive to others
because of diabetes 0.598 0.012 20.098 20.096 0.136 0.132
9 It is a burden for me how other people
react to my diabetes 0.589 0.094 20.052 20.184 0.032 0.184
4 Because of diabetes my relationship with
my partner has become worse 0.561 0.010 20.010 0.061 0.005 0.022
39 Because of diabetes other people treat me
like a “sick person” 0.549 0.072 0.126 20.030 20.007 20.002
26 Diabetes interferes with my future plans 0.467 20.069 0.088 0.129 0.252 0.033
18 Because of diabetes I feel anxious
or threatened 0.458 0.219 20.084 0.156 0.103 0.063
7 Because of diabetes I feel sad or depressed 0.416 0.019 20.072 0.127 0.226 0.201
13 Because of diabetes traveling is complicated
and troublesome 0.415 0.110 0.106 20.012 20.049 0.319
33 I am dissatisﬁed with the amount of time I
have to spend for medical consultations 0.414 20.033 0.055 0.188 0.063 0.100
20 Other people ﬁnd it hard to understand my
problems with diabetes treatment 0.396 0.011 0.058 0.095 0.073 0.190
15 Diabetes prevents me from spontaneous
physical activities 0.360 0.116 0.104 0.175 20.053 0.146
27 I get an uncomfortable feeling when I think
about the dangers of a severe episode
of low blood glucose 0.019 0.819 20.025 20.015 0.011 20.025
14 I get anxious and nervous when I think
about the dangers of episodes of low
blood glucose 20.056 0.772 20.054 0.080 0.010 0.182
10 I feel nervous and restless when I think
about episodes of low blood sugar 0.062 0.763 20.128 0.008 20.027 0.180
57 When I think about the dangers associated
with severe episodes of low blood glucose
I wonder how often I will remain unharmed 20.018 0.744 0.052 20.013 0.123 20.126
22 I unnecessarily worry too much about
episodes of low blood glucose 20.036 0.739 0.049 0.116 20.151 0.083
48 I am worried about having a severe episode
of low blood glucose at night 20.096 0.708 20.041 0.029 0.159 0.056
56 I am worried that I could easily panic in the
event of an episode of low blood sugar 0.173 0.667 0.048 20.045 0.025 20.120
43 It upsets my stomach when I think about
the dangers of severe episodes
of low blood glucose 0.130 0.664 0.013 0.089 20.125 20.019
Continued on p. 1122
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Table 2dContinued
Item no.
(English version) Item wording
Social
aspects
Fear of
hypoglycemia
Dietary
restraint
Physical
complaints
Anxiety
about future
Daily
hassles
36 I am worried that I could sustain physical
injury in the event of a severe episode
of low blood glucose 0.133 0.597 0.067 0.006 0.057 20.077
31 I am concerned about getting into
embarrassing situations because of
episodes of low blood glucose 0.211 0.587 0.023 20.090 0.068 0.071
52 It bothers me that I have to frequently think
about possible causes and mistakes after
episodes of low blood glucose 0.131 0.505 0.129 20.064 0.140 0.067
42 It bothers me that I cannot eat as spontaneously
as people who do not have diabetes 0.026 20.018 0.721 20.061 0.115 0.123
29 I wish I could eat more the way I want to,
without having to plan everything beforehand 0.007 20.004 0.711 0.017 0.039 0.122
47 I often cannot eat as much as I would like 0.045 20.005 0.676 0.193 20.065 20.016
37 It bothers me that I cannot eat like other people 0.152 0.034 0.670 20.079 0.028 0.071
55 I would like to eat a greater amount of certain
foods which increase my blood glucose strongly 20.042 0.012 0.669 0.075 0.071 20.035
24 I cannot eat as much as I want of certain foods 20.062 20.002 0.636 0.177 20.028 20.043
23 I have to give up good-tasting foods 0.053 0.121 0.514 0.182 20.097 20.053
54 It bothers me that I have to inject insulin before
I know how much I would really like to eat or
I really can eat 0.072 0.113 0.414 0.008 0.170 0.107
21 I feel physically unwell 0.180 20.003 20.063 0.728 0.001 0.098
32 I feel weak or lazy 0.045 0.024 0.038 0.689 0.052 0.129
11 I feel tired and exhausted 0.033 0.011 20.005 0.602 0.062 0.248
19 I suffer from thirst or having a dry mouth 20.117 0.128 0.036 0.550 0.047 0.096
17 Because of high blood glucose values after a
meal I often feel unwell or less efﬁcient 0.052 0.013 20.044 0.547 0.135 0.145
30 I suffer from frequent infections, itching
or skin problems 0.093 0.060 0.029 0.521 0.037 20.077
25 Because of diabetes I often have physical
complaints 0.237 20.006 0.078 0.516 0.033 20.058
50 Because of diabetes my physical strength is
restricted 0.360 20.019 0.100 0.480 20.006 20.052
3 I suffer from pain because of diabetes 0.180 0.046 20.017 0.459 0.045 20.017
16 I suffer from frequent urination 20.025 0.118 0.113 0.449 20.028 0.002
38 I am often worried about the long-term
complications of diabetes 20.059 0.206 0.047 0.055 0.731 20.050
8 I am worried about my future health 0.024 0.013 0.015 0.093 0.722 0.009
5 I am worried that my life could be shorter
because of diabetes 0.098 0.044 20.037 0.037 0.660 0.016
41 I have to frequently think about diabetes
and its consequences 0.202 0.069 0.150 20.034 0.497 0.052
46 I frequently worry that I may become helpless and
may need constant care later on 0.161 0.317 0.116 0.098 0.317 20.042
12 It bothers me that I have to spend so much time
on my diabetes treatment 0.311 20.034 0.188 0.057 0.002 0.552
1 It bothers me that I have to measure my blood
glucose so often 20.019 20.008 0.261 0.043 20.023 0.525
2 It is a burden for me that I need to constantly
think about my food plan 20.007 0.054 0.381 0.057 0.002 0.510
53 It bothers me how much diabetes controls my life 0.292 0.033 0.267 0.023 0.214 0.359
45 It bothers me that I have to take my diabetes
supplies (e.g., blood testing equipment)
with me whatever I do 0.233 0.070 0.253 20.105 0.095 0.305
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questions. Regression imputation was
used to impute values.
For determination of the number of
factors to extract from the EFA, goodness-
of-ﬁt indices, a scree plot of eigenvalues,
and the residual correlation matrix were
examined. A six-factor solution was in-
dicated and appeared to ﬁt the data well
with six interpretable factors [x2 =
2,999.2, df = 1,269, CFI = 0.898,
RMSEA = 0.053, and SRMR = 0.031 (Ta-
ble 2)]. This reﬂected the same factor
structure as the revised, 57-item, unpub-
lished German version of the DSQOLS
and mirrored the factor analysis of the
original German 44-item burden scale.
Only four items had a loading of .0.3
on a second factor (items 2, 12, 13, and
50), and none had a loading.0.4. For the
unrotated solution, six factors account for
57% of the total variance.
A CFA was run on the second half of
the database study data. Model ﬁt was
good (x2 = 4,182.3, df = 1,524, P ,
0.001, CFI = 0.85, RMSEA = 0.06, and
SRMR = 0.06) but was improved by al-
lowing nine residuals to covary and by
allowing item 41 to cross-load on the
social aspects subscale (x2 = 3,665.6, df =
1,514, P , 0.001, RMSEA = 0.05, CFI =
0.88, and SRMR = 0.05). Residuals were
covaried for items with very similar con-
tent and where we can assume that they
share speciﬁc variance in addition to the
common factor variance. Although im-
proving overall model ﬁt, their inclusion
had very little effect on the factor load-
ings. This model was then run on the
full database study dataset, where model
ﬁt was slightly better (x2 = 5,453.2, df =
1,514, P , 0.001, RMSEA = 0.05, CFI =
0.88, and SRMR = 0.05), although elimi-
nating the cross-loading did not make the
ﬁt appreciably worse (x2 = 5,531.5, df =
1,515, P , 0.001, RMSEA = 0.05, CFI =
0.88, and SRMR = 0.05). This was the pre-
ferred model.
The identiﬁcation of distinct (though
highly correlated) DSQOLS subscales
does not preclude the existence of a single
underlying diabetes-speciﬁc QoL scale. A
second-order factor analysis, where each
of the six factors loaded on a single
second-order factor, was conducted. Fit
of this model was not appreciably worse
than when the factors were allowed freely
to intercorrelate (x2 = 5,676.1, df = 1,524,
P, 0.001, RMSEA = 0.05, CFI = 0.88, and
SRMR = 0.05). This provided conﬁrmation
of an underlying QoL factor indicated by
six distinct subscales. Factor loadings of
each subscale on the second-order factor
were high (0.75–0.92). A one-factor model
did not ﬁt well (x2 = 13,009.1, df = 1,539,
P, 0.001, RMSEA = 0.09, CFI = 0.66, and
SRMR = 0.07).
Internal consistency reliability
(database study)
The seven DSQOLS subscales each had
excellent internal consistency: social as-
pects (N items = 18, a = 0.93), fear of
hypoglycemia (N items = 11, a = 0.94),
dietary restrictions (N items = 8, a =
0.89), physical complaints (N items =
10, a = 0.89), anxiety about the future
(N items = 5, a = 0.87), daily hassles (N
items = 5, a = 0.85), and Preference-
Weighted Treatment Satisfaction Scale
(N items = 20, a = 0.74). Item total corre-
lations for each subscale were all.0.5 (r =
0.51–0.79). Descriptive statistics for the
DSQOLS subscales showed a good distri-
bution of scores and low ﬂoor (score of 0)
and ceiling (score of 100) effects support-
ing the reliability of this scale (Table 1).
Concurrent validity (database study)
The six DSQOLS burden subscales were
signiﬁcantly intercorrelated (r = 0.52–
0.72, P , 0.001). The DSQOLS subscale
scores and the DSQOLS total score were
correlated (moderately to strongly) with
the ADDQoL AWI score and to a lesser
extent (weak to moderately) with the
diabetes-dependent ADDQoL overview
item (Table 3).
Discriminant validity (psychosocial
study and Irish study subsample)
As predicted, all the DSQOLS subscales
hadweak tomoderate, positive correlations
with depressed mood (WHO-5), ge-
neric QoL (ADDQoL overview item),
and “life satisfaction,” indicating that
they are measuring different constructs
(Table 3).
Known groups validity (database
study)
Participants with diagnosed diabetes-
related complications reported signiﬁ-
cantly lower (worse) scores on each of
the DSQOLS subscales and total score
with the exception of the dietary restric-
tions and daily hassles subscales, which
showed no difference (Table 4).
CONCLUSIONSdThis study aimed
to develop a linguistically validated U.K.
English translation of the German
DSQOLS and to examine its psychomet-
ric properties in adults with type 1 di-
abetes in the U.K. and Ireland. Following
forward-backward translation and recon-
ciliation and piloting (with adults with
type 1 diabetes and review by clinicians in
Ireland), face and content validity of the
U.K. English translation were established.
Examination of the scale structure
using EFA revealed a six-factor solution,
conﬁrmed with two independent CFAs,
demonstrating good ﬁt of this model to
available datasets. The structure reported
here reﬂects the six-factor structure of the
44-burden items from the original Ger-
man version. An equivalent factor struc-
ture was not expected because of the
modiﬁcations described earlier. Reliabil-
ity analyses were satisfactory for each
subscale. When a single factor was ﬁtted
to the six DSQOLS burden subscales, this
model provided a very good ﬁt to the
data, supporting the use of a DSQOLS
total score.
Moderate to strong correlations were
demonstrated between DSQOLS scores as
well as between the DSQOLS scores and
Table 3dCorrelations between DSQOLS subscales, ADDQoL, and WHO-5 Well-Being and
Life Satisfaction scales (psychosocial study and subsample of Irish study)
DSQOLS
ADDQoL
WHO-5
Well-Being
Life
SatisfactionAWI score
“My present
quality of life”
“If I did not
have diabetes”
Social aspects 0.78** 0.33* 0.38* 0.46** 0.50**
Fear of hypoglycemia 0.50** 0.20 0.30 0.31** 0.34**
Dietary restrictions 0.50** 0.27 0.47** 0.32** 0.27**
Physical complaints 0.78** 0.39* 0.32 0.54** 0.41**
Anxiety about future 0.66** 0.26 0.35* 0.35** 0.42**
Daily hassles 0.65** 0.38* 0.45** 0.43** 0.39**
Total score 0.82** 0.33 0.40* 0.50** 0.49**
n = 34–42 for ADDQoL measures. n = 245–252 for WHO-5 and Life Satisfaction measures. **P , 0.001,
*P , 0.05 for ADDQoL measures.
care.diabetesjournals.org DIABETES CARE, VOLUME 36, MAY 2013 1123
Cooke and Associates
the ADDQoL AWI score, suggesting that
these are assessing similar underlying
constructs providing evidence of concur-
rent validity. Given the mismatch be-
tween the structure of the two scales
[i.e., the DSQOLS has six subscales (sum-
marizing its 57 items) and the separate
20-item Preference-Weighted Treatment
Satisfaction Scale, and the ADDQoL has
one overall score based on the AWI for all
19 domains], the moderate correlations
are considered reasonable and the strong
correlations highly satisfactory. The
weaker correlations between the DSQOLS
subscales and the ADDQoL diabetes-
dependent overview item were to be
expected, as the latter is not considered
sufﬁcient to capture the full impact of di-
abetes on QoL (10).
Better scores on theDSQOLS subscales
were associated with greater well-being
(less depressed mood), generic QoL, and
life satisfaction, but the correlations were
sufﬁciently weak to indicate that various
scales measure different constructs. Partic-
ipants with diagnosed complications of
diabetes had signiﬁcantly worse scores on
four of six of the DSQOLS burden sub-
scales, the PWTSS, and DSQOLS total
score. This provided support for the ability
of this questionnaire tool to discriminate
between different groups of respondents.
Sensitivity of the DSQOLS to treat-
ment effects and test-retest reliability has
not been demonstrated in this study,
although work using the German version
has shown that it is sensitive to treatment
effects in a comparison of insulin pump
and multiple daily injection therapy (33).
Work is underway to examine the sensi-
tivity of this instrument for detecting
changes inQoL after structured education
for adults with type 1 diabetes.
There is a growing need for valid,
reliable, and responsive questionnaires to
assess outcomes in diabetes research and
clinical practice. Management of type 1
diabetes has evolved from ﬁxed daily
insulin doses (as prescribed) to more
ﬂexible but complex insulin dose self-
adjustment based upon carbohydrate
consumption and self-monitoring of
blood glucose levels. The evidence pre-
sented indicates that DSQOLS is an ap-
propriate tool for evaluating structured
education courses that promote ﬂexible
intensive insulin therapy. Like the
ADDQoL, the DSQOLS captures the
impact of diabetes on various aspects
of life known to be important for QoL
(e.g., family, friendships, and dietary
freedom) (10). However, the DSQOLS
also enables participants to indicate how
they feel about speciﬁc aspects of type 1 di-
abetes management, which are increasingly
common among those who have received
structured diabetes education, such as car-
bohydrate counting and ﬂexible insulin
dose adjustment. The DQOL questionnaire
(11) previously offered this type of ap-
proach to diabetes-speciﬁc QoL assessment
but has become outdated. Unlike existing
measures, the DSQOLS also offers the op-
portunity to assess individual treatment
goals as well as preference-weighted treat-
ment satisfaction in a single instrument.
The need for a focus on patient-
reported outcomes in addition to biomed-
ical end points is increasingly recognized
internationally (1,2,4). The length of the
DSQOLS may be considered a limitation;
we believe this is offset by the unique con-
tributions of its subscales, each capturing
important aspects of diabetes-speciﬁc
QoL and reducing the need for multiple
questionnaires to achieve a holistic assess-
ment. Although its length was not criti-
cized by participants in our studies, a
shorter version of the DSQOLS might be
more acceptable to respondents and,
hence, promote its wider use in clinical
and research environments. Validation
of a shorter version of this measure is un-
der development.
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